Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/68461
Title: UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort
Author: Vidal Taboada, José Manuel
López-López, A.
Salvado, M.
Lorenzo, L.
García, C.
Mahy Gehenne, Josette Nicole
Rodríguez Allué, Manuel José
Gámez, J.
Keywords: Esclerosi lateral amiotròfica
Genètica molecular
Malalties neurodegeneratives
Amyotrophic lateral sclerosis
Molecular genetics
Neurodegenerative Diseases
Issue Date: 11-Jul-2015
Publisher: Springer Verlag
Abstract: To investigate the association of functional variants of the human UNC13A gene with the risk of ALS, survival and the disease progression rate in a Spanish ALS cohort. 136 sporadic ALS (sALS) patients and 487 healthy controls were genotyped for the UNC13A rs12608932 variant. Clinical characterization of ALS patients included gender, age at first symptom, initial topography, disease progression rate, and survival. Genetic association was analyzed under five inheritance models. The sALS patients with the rs12608932(CC) genotype had an increased risk of ALS under a recessive genetic model [OR 2.16; 95 % CI (1.23, 3.8), p = 0.009; corrected p = 0.028]. Genotypes with a C allele are also associated with increased risk [OR 1.47; 95 % CI (1.11, 1.95); p = 0.008; corrected p = 0.023] under an additive model. sALS patients with a C/C genotype had a shorter survival than patients with A/A and A/C genotypes [HR 1.44; 95 % CI (1.11, 1.873); p = 0.007] under a recessive model. In an overdominant model, heterozygous patients had a longer survival than homozygous patients [HR 0.36; 95 % CI (0.22, 0.59); p = 0.001]. The rs12608932 genotypes modify the progression of symptoms measured using the ALSFRS-R. No association with age of onset, initial topography or rate of decline in FVC was found. Our results show that rs12608932 is a risk factor for ALS in the Spanish population and replicate the findings described in other populations. The rs12608932 is a modifying factor for survival and disease progression rate in our series. Our results also corroborated that it did not influence the age of onset.
Note: Versió postprint del document publicat a: http://dx.doi.org/10.1007/s00415-015-7843-z
It is part of: Journal of Neurology, 2015, vol. 262, num. 10, p. 2285-2292
Related resource: http://dx.doi.org/10.1007/s00415-015-7843-z
URI: http://hdl.handle.net/2445/68461
ISSN: 0340-5354
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)

Files in This Item:
File Description SizeFormat 
653244.pdf354.48 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.